Takeda Pharmaceutical Company Limited (TAK)
Company Info
US8740602052
874060205
Oct 27, 2008
Highlights
$46.23B
$0.24
61.67
0.42
$3.53T
$2.02T
$764.83B
$12.29 - $15.43
$17.20
0.20%
2.82
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
Takeda Pharmaceutical Company Limited (TAK) returned 13.52% year-to-date (YTD) and 18.05% over the past 12 months. Over the past 10 years, TAK returned -0.09% annually, underperforming the S&P 500 benchmark at 10.85%.
TAK
13.52%
-1.70%
10.35%
18.05%
5.09%
-1.38%
-0.09%
^GSPC (Benchmark)
0.51%
6.15%
-2.00%
12.92%
12.68%
14.19%
10.85%
Monthly Returns
The table below presents the monthly returns of TAK, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 1.13% | 7.62% | 3.19% | 2.82% | -1.70% | 13.52% | |||||||
| 2024 | 2.31% | -0.07% | -2.77% | -5.83% | 2.06% | -3.07% | 7.26% | 7.28% | -2.26% | -1.97% | -2.30% | -2.79% | -3.02% |
| 2023 | 1.28% | -2.85% | 9.42% | 0.67% | -4.52% | -0.82% | -2.86% | 0.92% | 2.51% | -12.09% | 4.04% | 0.85% | -4.87% |
| 2022 | 6.09% | 5.12% | -4.01% | 1.54% | -0.89% | -2.57% | 4.06% | -5.89% | -3.45% | 1.93% | 11.42% | 5.91% | 19.37% |
| 2021 | -3.13% | -5.22% | 11.64% | -8.54% | 2.34% | -1.52% | -1.96% | 0.55% | 1.12% | -14.41% | -4.78% | 2.10% | -21.64% |
| 2020 | -2.53% | -10.04% | -10.39% | 18.18% | 8.70% | -8.05% | 1.51% | 2.25% | -2.19% | -13.73% | 15.85% | 2.08% | -3.88% |
| 2019 | 18.73% | 0.45% | 4.78% | -10.26% | -7.17% | 4.30% | -0.57% | -4.20% | 3.86% | 4.48% | 12.97% | -2.81% | 23.22% |
| 2018 | 3.69% | -3.54% | -11.88% | -13.11% | -4.76% | 3.47% | 1.44% | -1.56% | 5.82% | -1.26% | -10.90% | -10.53% | -37.24% |
| 2017 | 0.94% | 11.01% | 4.86% | 5.06% | 3.79% | -1.36% | 4.64% | 4.40% | 2.31% | 2.28% | -2.30% | 2.82% | 45.13% |
| 2016 | -3.24% | -1.36% | -1.36% | 5.00% | -9.97% | -0.14% | 5.25% | -2.65% | 11.63% | -6.28% | -7.88% | 0.48% | -11.83% |
| 2015 | 20.91% | 2.39% | 0.17% | 2.60% | -5.53% | -0.21% | 4.42% | -2.99% | -8.26% | 13.26% | -1.33% | 2.41% | 27.59% |
| 2014 | 0.91% | 3.31% | 0.35% | -5.70% | 1.39% | 2.60% | -1.68% | -0.13% | -1.83% | 1.43% | -5.40% | -0.57% | -5.61% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of TAK is 74, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Takeda Pharmaceutical Company Limited (TAK) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
Takeda Pharmaceutical Company Limited provided a 2.22% dividend yield over the last twelve months, with an annual payout of $0.33 per share. The company has been increasing its dividends for 2 consecutive years.
| Period | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $0.33 | $0.63 | $0.63 | $0.58 | $0.79 | $0.70 | $0.98 | $1.40 | $1.46 | $1.44 | $1.34 | $1.04 |
Dividend yield | 2.22% | 4.78% | 4.41% | 3.69% | 5.80% | 3.84% | 4.94% | 8.33% | 5.14% | 6.91% | 5.34% | 5.03% |
Monthly Dividends
The table displays the monthly dividend distributions for Takeda Pharmaceutical Company Limited. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| 2024 | $0.00 | $0.00 | $0.30 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.33 | $0.00 | $0.00 | $0.00 | $0.63 |
| 2023 | $0.00 | $0.00 | $0.31 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.32 | $0.00 | $0.00 | $0.00 | $0.63 |
| 2022 | $0.00 | $0.00 | $0.28 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.30 | $0.00 | $0.00 | $0.00 | $0.58 |
| 2021 | $0.00 | $0.00 | $0.40 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.39 | $0.00 | $0.00 | $0.00 | $0.79 |
| 2020 | $0.00 | $0.00 | $0.32 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.38 | $0.00 | $0.00 | $0.00 | $0.70 |
| 2019 | $0.00 | $0.00 | $0.66 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.32 | $0.00 | $0.00 | $0.00 | $0.98 |
| 2018 | $0.00 | $0.00 | $0.70 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.70 | $0.00 | $0.00 | $0.00 | $1.40 |
| 2017 | $0.00 | $0.00 | $0.76 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.71 | $0.00 | $0.00 | $0.00 | $1.46 |
| 2016 | $0.00 | $0.00 | $0.76 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.68 | $0.00 | $0.00 | $0.00 | $1.44 |
| 2015 | $0.00 | $0.00 | $0.69 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.65 | $0.00 | $0.00 | $0.00 | $1.34 |
| 2014 | $0.37 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.67 | $0.00 | $0.00 | $0.00 | $1.04 |
Dividend Yield & Payout
Dividend Yield
Takeda Pharmaceutical Company Limited has a dividend yield of 2.22%, which is quite average when compared to the overall market.
Payout Ratio
Takeda Pharmaceutical Company Limited has a payout ratio of 1.14%, which is below the market average. This means Takeda Pharmaceutical Company Limited returns a smaller proportion of its earnings to shareholders as dividends, suggesting it retains a higher portion for reinvestment, growth, or debt payment.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the Takeda Pharmaceutical Company Limited. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Takeda Pharmaceutical Company Limited was 52.76%, occurring on Mar 18, 2020. The portfolio has not yet recovered.
The current Takeda Pharmaceutical Company Limited drawdown is 32.59%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -52.76% | Jan 29, 2018 | 537 | Mar 18, 2020 | — | — | — |
| -42.78% | Jan 5, 2009 | 44 | Mar 9, 2009 | 404 | Oct 13, 2010 | 448 |
| -21.05% | Apr 26, 2013 | 28 | Jun 5, 2013 | 438 | Mar 3, 2015 | 466 |
| -18.14% | Mar 9, 2015 | 329 | Jun 24, 2016 | 192 | Mar 30, 2017 | 521 |
| -17.77% | Mar 1, 2011 | 193 | Dec 1, 2011 | 182 | Aug 22, 2012 | 375 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Takeda Pharmaceutical Company Limited over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of Takeda Pharmaceutical Company Limited, comparing actual results with analytics estimates. In the past quarter, the company did not meet analyst expectations for EPS, resulting in a surprise of -92.4%.
Valuation
The Valuation section provides an overview of how Takeda Pharmaceutical Company Limited is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for TAK, comparing it with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, TAK has a P/E ratio of 61.7. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for TAK compared to other companies in the Drug Manufacturers - Specialty & Generic industry. TAK currently has a PEG ratio of 0.4. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for TAK relative to other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, TAK has a P/S ratio of 0.0. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for TAK in comparison with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, TAK has a P/B value of 1.0. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |